| Mohammad Waseem Farra, MD | |
|
29275 W 10 Mile Rd, Farmington Hills, MI 48336-2817 | |
| (248) 350-2722 | |
| (248) 350-0154 |
| Full Name | Mohammad Waseem Farra |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 34 Years |
| Location | 29275 W 10 Mile Rd, Farmington Hills, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609871771 | NPI | - | NPPES |
| 0F37521 | Other | MI | BLUE CROSS BLUE SHIELD |
| 4292155 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 4301067318 (Michigan) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 4301067318 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Consultants In Sleep And Pulmonary Medicine Pllc | 1658333125 | 12 |
News Archive
Idenix Pharmaceuticals, Inc.a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced presentations of data on IDX184, a once-daily novel liver-targeted nucleotide prodrug of 2'-methyl guanosine (2'MeG) for the treatment of HCV, at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) currently being held in Boston, Massachusetts.
Peer support for patients with bipolar disorder may help improve adherence to online psychoeducation programs, study findings suggest.
When a coronary artery is obstructed by atheroma, blood flow is depressed or even arrested. This causes hypoxia of cardiac cells associated with the deprivation of nutrients. In clinic, the first objective is to restore blood flow. However, this is associated with a burst in oxidation of cellular proteins and lipids. This oxidation enhances cell death and participates to the so-called reperfusion injury.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced results from a pre-clinical pharmacokinetic study showing the ability of NexACT to enable rectal delivery of biologics, such as human antibodies.
A new study has shown that more than half (53.1%) of office-based physicians in the U.S., across specialty areas, recommended at least one complementary health approach (CHA) to their patients during the previous 12 months, with female physicians (63.2%) more likely to recommend a CHA than male physicians (49.3%).
› Verified 1 days ago
| Entity Name | Consultants In Sleep & Pulmonary Medicine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740353069 PECOS PAC ID: 1658333125 Enrollment ID: O20050913000986 |
News Archive
Idenix Pharmaceuticals, Inc.a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced presentations of data on IDX184, a once-daily novel liver-targeted nucleotide prodrug of 2'-methyl guanosine (2'MeG) for the treatment of HCV, at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) currently being held in Boston, Massachusetts.
Peer support for patients with bipolar disorder may help improve adherence to online psychoeducation programs, study findings suggest.
When a coronary artery is obstructed by atheroma, blood flow is depressed or even arrested. This causes hypoxia of cardiac cells associated with the deprivation of nutrients. In clinic, the first objective is to restore blood flow. However, this is associated with a burst in oxidation of cellular proteins and lipids. This oxidation enhances cell death and participates to the so-called reperfusion injury.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced results from a pre-clinical pharmacokinetic study showing the ability of NexACT to enable rectal delivery of biologics, such as human antibodies.
A new study has shown that more than half (53.1%) of office-based physicians in the U.S., across specialty areas, recommended at least one complementary health approach (CHA) to their patients during the previous 12 months, with female physicians (63.2%) more likely to recommend a CHA than male physicians (49.3%).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohammad Waseem Farra, MD 29275 W 10 Mile Rd, Farmington Hills, MI 48336-2817 Ph: (248) 350-2722 | Mohammad Waseem Farra, MD 29275 W 10 Mile Rd, Farmington Hills, MI 48336-2817 Ph: (248) 350-2722 |
News Archive
Idenix Pharmaceuticals, Inc.a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced presentations of data on IDX184, a once-daily novel liver-targeted nucleotide prodrug of 2'-methyl guanosine (2'MeG) for the treatment of HCV, at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) currently being held in Boston, Massachusetts.
Peer support for patients with bipolar disorder may help improve adherence to online psychoeducation programs, study findings suggest.
When a coronary artery is obstructed by atheroma, blood flow is depressed or even arrested. This causes hypoxia of cardiac cells associated with the deprivation of nutrients. In clinic, the first objective is to restore blood flow. However, this is associated with a burst in oxidation of cellular proteins and lipids. This oxidation enhances cell death and participates to the so-called reperfusion injury.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced results from a pre-clinical pharmacokinetic study showing the ability of NexACT to enable rectal delivery of biologics, such as human antibodies.
A new study has shown that more than half (53.1%) of office-based physicians in the U.S., across specialty areas, recommended at least one complementary health approach (CHA) to their patients during the previous 12 months, with female physicians (63.2%) more likely to recommend a CHA than male physicians (49.3%).
› Verified 1 days ago
Kali Allis, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-417-8000 | |
Dr. Jyothsna Yalavarthi, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 734-464-0887 Fax: 734-402-0254 | |
Dr. Roberto Mauro Gamarra, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 30055 Northwestern Hwy, Suite 250, Farmington Hills, MI 48334 Phone: 248-985-5000 Fax: 248-985-5500 | |
Dr. Jared Grodman, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-471-8232 | |
Justin Cykiert, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 28050 Grand River Ave, Farmington Hills, MI 48336 Phone: 248-615-0777 | |
Larry A Wickless, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 28080 Grand River Ave, Suite 306, Farmington Hills, MI 48336 Phone: 248-471-8982 Fax: 248-426-7350 | |
Dr. Allan W Chernick, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 29645 W 14 Mile Rd, Ste 200, Farmington Hills, MI 48334 Phone: 248-932-3700 Fax: 248-932-0958 |